Treatment of chronic discoid lupus erythematosus with an oral gold compound (auranofin).

Abstract	Twenty-three patients with severe longstanding discoid lupus erythematosus, unresponsive to conventional treatments, were treated with oral gold in a multicentre open study. Nineteen patients showed clinical improvement and in four of these there was complete resolution of lesions. Adverse reactions were generally mild and self limiting.
Authors	K Dalziel, G Going, P H Cartwright, R Marks, G W Beveridge, N R Rowell
Journal	The British journal of dermatology (Br J Dermatol) Vol. 115 Issue 2 Pg. 211-6 (Aug 1986) ISSN: 0007-0963 [Print] England
PMID	3091062 (Publication Type: Clinical Trial, Journal Article)
Chemical References	Aurothioglucose Auranofin Gold
Topics	Adolescent Adult Aged Auranofin Aurothioglucose (adverse effects, analogs & derivatives, therapeutic use) Chronic Disease Clinical Trials as Topic Female Gold (analogs & derivatives) Humans Lupus Erythematosus, Discoid (drug therapy) Male Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!